COMMUNIQUÉS West-GlobeNewswire

‘Disparate-Impact’ Thinking Is Destroying Medicine, States President of the Association of American Physicians and Surgeons (AAPS)
06/06/2024
TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Any notion that medicine was immune to the culture shocks in our nation was destroyed by the intersection of the George Floyd response and COVID-era policy, writes [...]
Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2
06/06/2024
WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically [...]
BioSenic announces 2023 full year results
06/06/2024
PRESS RELEASE - REGULATED INFIRMATION BioSenic stopped the patient recruitment for its Phase 2b ALLOB trial in mid-2023. BioSenic has prepared a global restructuring plan covering the years 2024-2032 and will actively [...]
BioSenic publie ses résultats annuels 2023
06/06/2024
COMMUNIQUÉ DE PRESSE – INFORMATION REGLEMENTEE BioSenic a arrêté le recrutement des patients pour son essai de phase 2b ALLOB à la mi-2023. BioSenic a préparé un plan de restructuration global couvrant les années 2024- [...]
Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024
06/06/2024
Gloperba ® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Gout is a painful arthritic disorder affecting an estimated 9.2 [...]
Bad-faith Physician Peer Review May Violate False Claims Act and Other Laws, according to Journal of American Physicians and Surgeons
06/06/2024
TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Physicians targeted for career destruction through hospital sham peer review have limited means of defense , but there are ways in which they can play offense, writes [...]
Nextech Appoints Rusty Frantz as Chief Executive Officer
06/06/2024
Experienced Healthcare Technology Executive to Lead Next Stage of Growth TAMPA, Fla., June 06, 2024 (GLOBE NEWSWIRE) -- Nextech, a market leader of comprehensive technology solutions for specialty physician practices, [...]
Repurposed Drugs Needed for COVID-19, according to Journal of American Physicians and Surgeons
06/06/2024
TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Drug repurposing, an old concept of using already approved medications for the treatment of new conditions, emerged as one of most divisive elements of the response to [...]
New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons
06/06/2024
TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Patients taking new weight loss/diabetes drugs such as semaglutide (Wegovy™), and their doctors, need to be aware of the significant risk they pose for sedation or [...]
Los Angeles Students Experience Behavioral Transformation Through Mindfulness Program
06/06/2024
Empowering Students with Emotional Resilience and Self-awareness WBP's 10-month, Weekly, Mindfulness Curriculum Yields Remarkable Results in LA Schools LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- Worthy Beyond [...]
TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
06/06/2024
Company restructures executive compensation and reduces external consulting fees Expects to reduce cash used in operations by 30% (Approximately $500,000) by end of 2024 Company to continue to invest in sales personnel [...]
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
06/06/2024
– Final positive CORE-001 safety and efficacy findings were published simultaneously online by Nature Medicine and featured at ASCO 2024 – – 54% complete response (CR) rate in the intention-to-treat population at 24- [...]
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
06/06/2024
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/06/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Market update : FOCUS-27 transformation project financing
06/06/2024
Press release Paris – June 6, 2024 – EUROAPI informs that it has decided to be assisted by a mandataire ad hoc in its discussions initiated in February 2024 regarding the mid-term and long-term financing of its FOCUS-27 [...]
Information marché Financement du projet de transformation FOCUS-27
06/06/2024
Communiqué de presse Paris – Le 6 juin 2024 – EUROAPI informe avoir décidé de se faire accompagner par un mandataire ad hoc dans les discussions entamées en février 2024 concernant le financement à moyen et long terme [...]
ACT Foundation congratulates Quebec Minister of Education on announcement to expand AEDs to all public schools
06/06/2024
OTTAWA, June 06, 2024 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation congratulates Education Minister Bernard Drainville for his announcement to ensure Automated External Defibrillators (AEDs) in [...]
La Fondation ACT salue la décision du ministre de l'Éducation du Québec d’étendre les défibrillateurs à toutes les écoles publiques
06/06/2024
OTTAWA, 06 juin 2024 (GLOBE NEWSWIRE) -- La Fondation (ACT) des soins avancés en urgence coronarienne accueille favorablement l’annonce faite par le ministre de l'Éducation, Bernard Drainville, visant à assurer la [...]
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
06/06/2024
In t he HBV003 trial, 67% of participants had HBsAg <10 IU/mL and 19% of participants had undetectable HBsAg when assessed for NUC discontinuation (end of treatment) or later, and 76% of participants were eligible [...]

Pages